Multiple flavonoid-binding sites within multidrug resistance protein MRP1

被引:0
|
作者
D. Trompier
H. Baubichon-Cortay
X.-B Chang
M. Maitrejean
D. Barron
J. R. Riordan
A. Di Pietro
机构
[1] UMR5086 CNRS/Université Claude Bernard-Lyon I,Institut de Biologie et Chimie des Protéines
[2] IFR128 BioSciences Lyon-Gerland,Mayo Clinic Scottsdale
[3] S.C. Johnson Medical Research Center,Laboratoire des Produits Naturels
[4] Université Claude Bernard-Lyon I,undefined
来源
Cellular and Molecular Life Sciences CMLS | 2003年 / 60卷
关键词
Multidrug resistance protein 1 (MRP1); multidrug resistance (MDR); flavonoid; nucleotide-binding domain (NBD); chemosensitization; drug-binding site; ABC transporter;
D O I
暂无
中图分类号
学科分类号
摘要
Recombinant nucleotide-binding domains (NBDs) from human multidrug resistance protein MRP1 were overexpressed in bacteria and purified to measure their direct interaction with high-affinity flavonoids, and to evaluate a potential correlation with inhibition of MRP1-mediated transport activity and reversion of cellular multidrug resistance. Among different classes of flavonoids, dehydrosilybin exhibited the highest affinity for both NBDs, the binding to N-terminal NBD1 being prevented by ATP. Dehydrosilybin increased vanadate-induced 8-N3-[α-32P]ADP trapping, indicating stimulation of ATPase activity. In contrast, dehydrosilybin strongly inhibited leukotriene C4 (LTC4) transport by membrane vesicles from MRP1-transfected cells, independently of reduced glutathione, and chemosensitized cell growth to vincristine. Hydrophobic C-isoprenylation of dehydrosilybin increased the binding affinity for NBD1, but outsite the ATP site, lowered the increase in vanadate-induced 8-N3-[α-32P]ADP trapping, weakened inhibition of LTC4 transport which became glutathione dependent, and induced some cross-resistance. The overall results indicate multiple binding sites for dehydrosilybin and its derivatives, on both cytosolic and transmembrane domains of MRP1.
引用
收藏
页码:2164 / 2177
页数:13
相关论文
共 50 条
  • [41] Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer
    Dhasmana, Divya
    Singh, Ashutosh
    Shukla, Rohit
    Tripathi, Timir
    Garg, Neha
    SCIENTIFIC REPORTS, 2018, 8
  • [42] Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: The impact on MRP activity.
    van der Kolk, DM
    Vellenga, E
    van der Veen, AY
    Noordhoek, L
    Timmer-Bosscha, H
    Ossenkoppele, GJ
    Raymakers, R
    Muller, M
    van den Berg, E
    de Vries, EGE
    BLOOD, 1999, 94 (10) : 197B - 197B
  • [43] Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future
    Cole, Susan P. C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 95 - +
  • [44] Structural and Functional Properties of Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
    He, S. -M.
    Li, R.
    Kanwar, J. R.
    Zhou, S. -F.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (03) : 439 - 481
  • [45] Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer
    Divya Dhasmana
    Ashutosh Singh
    Rohit Shukla
    Timir Tripathi
    Neha Garg
    Scientific Reports, 8
  • [46] Monomethylarsenic Diglutathione Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
    Carew, Michael W.
    Naranmandura, Hua
    Shukalek, Caley B.
    Le, X. Chris
    Leslie, Elaine M.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (12) : 2298 - 2304
  • [47] Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters
    Leslie, EM
    Deeley, RG
    Cole, SPC
    TOXICOLOGY, 2001, 167 (01) : 3 - 23
  • [48] Upregulation in the expression of multidrug resistance protein Mrp1 mRNA and protein by increased bilirubin production in rat
    Cekic, D
    Bellarosa, C
    Garcia-Mediavilla, MV
    Rigato, I
    Pascolo, L
    Ostrow, JD
    Tiribelli, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 311 (04) : 891 - 896
  • [49] Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain
    Bakos, E
    Evers, R
    Szakács, G
    Tusnády, GE
    Welker, E
    Szabó, K
    de Haas, M
    van Deemter, L
    Borst, P
    Váradi, A
    Sarkadi, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) : 32167 - 32175
  • [50] Multidrug resistance protein MRP1, glutathione, and related enzymes -: Their importance in acute myeloid leukemia
    van der Kolk, DM
    Vellenga, E
    Müller, M
    de Vries, EGE
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA III, 1999, 457 : 187 - 198